|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 44, 1199-1208, June 2003 Fatty acid flux suppresses fatty acid synthesis in hamster intestine independently of SREBP-1 expression
Department of Veterans Affairs and Department of Internal Medicine, University of Iowa, Iowa City, IA 52242 Published, JLR Papers in Press, March 16, 2003. DOI 10.1194/jlr.M300013-JLR200
1 To whom correspondence should be addressed. e-mail: f-jeffrey-field{at}uiowa.edu
Hamsters were fed a control diet or diets containing palm, olive, safflower, or fish oil for 2 weeks. In villus cell populations from duodenum, jejunum, and ileum, rates of intestinal fatty acid and cholesterol synthesis were estimated, as were sterol regulatory element-binding protein (SREBP)-1a, SREBP-1c, SREBP-2, HMG-CoA synthase, fatty acid synthase, ATP citrate lyase, acetyl-CoA carboxylase mRNA levels, and SREBP-1 and SREBP-2 mass. Plasma cholesterol and triacylglcerol levels were increased in animals ingesting palm oil and decreased in animals ingesting fish oil. Fatty acid synthesis and fatty acid synthase activity were decreased in the proximal intestine of animals ingesting all the fat-containing diets. Intestinal cholesterol synthesis was unaltered. In animals fed fat, SREBP-1c gene expression was modestly increased in the duodenum of hamsters fed palm oil or olive oil, and decreased in animals ingesting safflower oil or fish oil. Fatty acid synthase, acetyl-CoA carboxylase, ATP citrate lyase, SREBP-2, and HMG-CoA synthase mRNA levels were not altered, nor were SREBP-1 or SREBP-2 mass. In the intestine, dietary polyunsaturated fatty acids suppress SREBP-1c mRNA without altering expression of its target genes, fatty acid synthase, acetyl-CoA carboxylase, or ATP citrate lyase. Fatty acid influx decreases intestinal fatty acid synthesis by a posttranscriptional mechanism independent of the SREBP pathway.
Abbreviations: SREBP, sterol regulatory element-binding protein Supplementary key words fat diet cholesterol triacylglycerol gene expression
Sterol regulatory element-binding proteins (SREBPs) are transcription factors that regulate the transcription of several genes in both the cholesterol and fatty acid synthetic pathways [reviewed in ref. (1)]. SREBP-1a and SREBP-1c are derived from a single gene that uses an alternative transcriptional start site to produce the two isoforms of SREBP-1 (2). SREBP-2 is a product of a separate gene and has 50% homology to SREBP-1. All three SREBPs are synthesized as 125 kDa precursor proteins bound to the endoplasmic reticulum. In times of cholesterol deficiency, a two-step proteolysis of the precursor protein releases a 68 kDa N-terminal end of the protein producing the active transcription factor. This "mature" or nuclear form enters the nucleus and binds to a 10 bp sterol regulatory element in promoter regions of target genes that result in enhanced transcription (37). Although there is overlap in their gene targets, SREBP-2 preferentially enhances genes in the cholesterol synthetic pathway, whereas SREBP-1, particularly 1c, tends to be more active in regulating genes of the fatty acid synthetic pathway (811). Characterization and regulation of SREBPs have been extensively studied in several cell culture model systems and, in particular, liver of intact animals [reviewed in ref. (12)]. Pertinent to the objectives of the present study, previous studies have investigated the effect of dietary fat on the expression of SREBP-1 in liver (13, 14). The combined results of these studies demonstrate quite clearly that dietary polyunsaturated fats, either of the n-6 or n-3 class, decrease gene and protein expression of SREBP-1, which in turn are associated with a decrease in fatty acid synthase gene expression. These results have provided a potential mechanism for earlier observations that showed that dietary polyunsaturated fatty acids decrease transcription of genes responsible for controlling hepatic lipogenesis (15). In addition, from results in SREBP-1c transgenic animals, and in animals in which fasting, refeeding protocols were employed to induce fatty acid biosynthesis, it also seems clear in liver that SREBP-1c regulates fatty acid synthesis (8, 16). Thus, in liver, SREBP-1c regulates genes of fatty acid biosynthesis and, in turn, SREBP-1 expression is regulated by changes in dietary fat. Although much is known about the regulation of cholesterol and fatty acid synthesis by dietary lipids in liver and how SREBPs might play a role in regulating these pathways, there remains a paucity of information regarding the regulation of these pathways in the intestine. This is unfortunate. The intestine is, after all, the first organ to encounter these dietary lipids (in very substantial amounts) and is responsible for transporting them in a form that can be taken up by peripheral tissues and liver. Our previous efforts have focused on understanding mechanisms for the regulation of intestinal cholesterol metabolism and what roles SREBPs play in this process (17, 18). There is, however, no information that addresses whether fatty acid synthesis is regulated by changes in fatty acid flux and what role, if any, SREBP-1 or SREBP-2 might have in this process in the gut. The present study was undertaken, therefore, to examine if changes in dietary fatty acid flux regulate intestinal fatty acid biosynthesis and whether SREBPs, particularly SREBP-1c, play a role in fatty acid synthesis in this organ.
[3H]water (1 Ci/mmole) was purchased from ICN Biochemicals, Inc., Irvine, CA. Protease inhibitors and Tri Reagent were purchased from Sigma (St. Louis, MO). RNase-free DNase was purchased from Promega Corporation, Madison, WI. Superscript II RNase H-reverse transcriptase was obtained from Invitrogen Life Technologies, Carlsbad, CA. SYBR Green PCR mix was purchased from Applied Biosystems, Foster City, CA. All components for the diets except the oils were purchased from Harlan/Teklad Research Diets, Madison, WI. Corn oil, olive oil, and safflower oil were purchased from a local grocery store. Palm oil was obtained from Craftexpress, Memphis, TN. Fish oil (50:05 TG) was a generous gift from Ocean Nutrition Canada Ltd., Bedford, Nova Scotia, Canada.
Animals and diet
Fatty acid analysis of the diets and intestinal cells The lipids from the diet or the cell fractions were extracted with 0.5 ml of hexane-2-propanol-water, 3:2:0.1 (v/v/v), followed by 4 ml of methanol. The solvent from the lipid extract of the diets was evaporated under nitrogen, and fatty acid methyl esters were prepared using 15% w/v boron triflouride-methanol reagent. The cellular total lipid extract was applied on a silica gel plate and developed with hexane-diethyl ether-acetic acid-methanol (70:30:1:1, v/v/v/v) to separate phospholipids from other lipids. The phospholipids from the silica gel were eluted by adding 4.5 ml water followed by 5 ml of methanol and 5 ml of chloroform. The mixture was mixed by vortexing, and phases were separated by centrifugation. The lower chloroform layer was collected, and the solvent was removed under nitrogen. The fatty acids in the phospholipid fraction were transesterified using 15% w/v boron trifluoride-methanol reagent. The fatty acid methyl esters were extracted in hexane and analyzed by gas liquid chromatography on a Supelco GP 10% SP-2330 on a 100:120 chromosorb w AW column using a Hewlett-Packard 5890 gas chromatograph. The oven was programmed to an initial temperature of 180°C for 8 min followed by heating at 3°C/min to 210°C, where it was held for 15 min. The fatty acids were identified by comparison of retention time with samples of known fatty acid composition. Table 2 shows the percent of the major fatty acids found in the respective diets.
Isolation of enterocytes The cells along the villus axis were isolated from duodenum, jejunum, and ileum segments of the hamster intestine, as described previously by Field et al. (18).
Estimation of relative expression of mRNA levels by real-time RT-PCR
Immunoblot analysis The methods for estimation of SREBP mass in the intestinal cells by immunoblotting have been described previously (18).
Cholesterol and fatty acid synthesis
Fatty acid synthase assay
Other analyses
Statistical analysis
Lipid parameters Hamsters were fed ad lib for 2 weeks diets consisting of high carbohydrate and low fat (control), or diets in which the carbohydrate was replaced with the following oils (10% wt/wt): palm oil (containing 33% of its fatty acids as 16:0, v/v), olive oil (64% 18:1, v/v), safflower oil (69% 18:2, v/v), or cholesterol-free fish oil (44% 20:5 and 22:6). Table 4 shows the characteristics of these animals after the 2 week dietary period. Animals fed palm, olive, and safflower oils gained similar amounts of weight over the period. Like previous observations (13), despite having similar daily energy intakes, weight gain of animals fed the fish oil diet was similar to those animals fed the high-carbohydrate low-fat control diet.
Plasma cholesterol and triacylglycerol levels were analyzed. Plasma cholesterol and triacylglycerol concentrations were higher in the palm oil group than in controls (214 vs. 162 mg/dl and 262 vs. 168 mg/dl, respectively), and were lower in the fish oil group than in all other groups. To examine if the type of dietary fat altered the fatty acid composition of intestinal membranes, the fatty acid composition of phospholipids isolated from cells prepared from duodenum, jejunum, and ileum of animals fed the respective diets was analyzed. For brevity, only data from the duodenum are shown, as the changes observed in the proximal intestine were reflective of the changes in jejunum and ileum (Table 5). To simplify and highlight the differences, the major fatty acid found in the respective fat diet is depicted in bold. It is clear from these results that intestinal phospholipids were enriched in the particular fatty acid that is most abundant in the fat diet. Total cholesterol content of whole homogenates prepared from duodenum, jejunum, and ileum were similar in animals from all five dietary groups (unpublished results).
Effect of dietary fat on intestinal fatty acid and cholesterol synthesis Following the dietary period, animals were injected into the peritoneum with tritiated water. After 4 h, the intestines were removed and divided into three equal segments corresponding to duodenum, jejunum, and ileum. Isolated cells were prepared from the three segments representing upper (fractions 1 and 2), middle (fractions 3 and 4), and lower (fraction 5) villus cells (18). The incorporation of tritiated water into fatty acids (Fig. 1) and cholesterol (Fig. 2) was determined in these cell fractions as an estimate of the rates of synthesis for these lipids. The bottom panels of Figs. 1 and 2 show the incorporation of labeled water into fatty acids and cholesterol in the different cell fractions along the villus axis. The top panels combine the results for the three segments. Irrespective of the dietary group, rates of fatty acid synthesis were higher in cells of the lower villus compared with rates observed in the upper villus. Overall rates of fatty acid synthesis were similar along the length of the small intestine. Duodenal fatty acid synthesis was diminished by all fat-containing diets, relative to controls. Changes in jejunal fatty acid synthesis exhibited a pattern similar to that in duodenum, except that the fish oil group did not differ from controls. For ileal fatty acid synthesis, only the palm oil group was lower than controls. There were no significant differences in rates of intestinal fatty acid synthesis among the animals fed diets enriched in fat. Thus, increased fatty acid flux through the proximal intestine decreases the rate of fatty acid synthesis. Suppression of fatty acid synthesis by fatty acid flux is independent of the type of fat ingested.
Rates of cholesterol synthesis were also higher in cells of the lower villus, irrespective of the diet ingested (Fig. 2). The ingestion of fat did not significantly alter rates of intestinal cholesterol synthesis along the villus axis (bottom panel) or down the length of the gut (top panel).
Effect of dietary fat on intestinal SREBP gene expression and their target genes
In contrast, gene expressions for SREBP-2, HMG-CoA synthase, fatty acid synthase, acetyl-CoA carboxylase, and ATP citrate lyase were not altered by any of the fat-enriched diets (Fig. 3B).
Effects of dietary fat on SREBP-1 and SREBP-2 mass
Effect of dietary fat on fatty acid synthase activity The results indicate that in the intestine, fatty acid influx suppresses fatty acid synthesis without decreasing gene expression of three key regulatory enzymes in the fatty acid synthetic pathway, fatty acid synthase, acetyl-CoA carboxylase, and ATP citrate lyase. It could be argued that in animals ingesting fat, water incorporation into fatty acids could be decreased secondary to a lack of available substrates for fatty acid synthase and may not be due to a decrease in fatty acid synthase activity per se. To address this, fatty acid synthase activity was measured in cytosol prepared from isolated cells obtained from duodenum and jejunum of animals on the respective diets (Fig. 5 shows these data). Fatty acid synthase activity was significantly decreased in duodenum of animals ingesting fat compared with controls. Similar results were appreciated in the jejunum, though the changes were more modest than those observed in the duodenum. Because the in vitro assay for fatty acid synthase contains saturating amounts of substrates, the results suggest that in the intact animal, the decrease in intestinal fatty acid synthesis by dietary fatty acids is not due to the limited availability of substrates for fatty acid synthase but is likely related to a direct effect upon the enzyme.
The results of the present study clearly demonstrate that the ingestion of fat decreases fatty acid synthesis in the proximal small intestine. To our knowledge, this has not been demonstrated previously. Was this finding unexpected? In liver, end-product feedback inhibition of cholesterol, fatty acid, and bile acid synthesis has been repeatedly shown (15, 20, 21). Should the intestine, another organ that receives a significant influx of lipids, differ from liver? Unlike hepatocytes, intestinal cells are not in the business of storing lipids for later use. Instead, the task of an intestinal cell is to transport lipids efficiently and rapidly from the exterior compartment to the interior compartment. Thus, it seemed plausible to speculate that transported lipids might bypass potential intracellular regulatory lipid pools and thus not cause end-product feedback inhibition. Indeed, an increased influx of cholesterol does not cause feedback inhibition of cholesterol synthesis in rodent intestine (18, 22). The fact that increased fatty acid flux suppressed intestinal fatty acid biosynthesis suggests that there is a mechanism by which fatty acids suppress their own synthesis in this organ. Unlike in the liver, however, the mechanism is not related to an alteration in SREBP mass or gene expression of rate-controlling enzymes in the fatty acid synthetic pathway (discussed below). In the proximal small intestine, all diets enriched in fat similarly suppressed fatty acid synthesis, suggesting that inhibition of fatty acid synthesis is independent of the type of fatty acid in excess. The data also suggest that suppression of fatty acid synthesis is likely related to the quantity of fatty acid flux. Only in the duodenum and jejunum, sites of most lipid transport, were rates of fatty acid synthesis decreased. As mentioned, the results do not support a role for intestinal SREBP-1c or the SREBP pathway in regulating fatty acid synthesis following fatty acid influx. In the proximal intestine, all dietary fats similarly suppressed fatty acid biosynthesis, and yet, only in animals ingesting fish oil was SREBP-1c gene expression decreased. In fact, SREBP-1c gene expression was modestly increased in hamsters fed palm or olive oil. Moreover, SREBP-1 mass was not altered in the intestines of hamsters ingesting fat, including fish oil animals in which SREBP-1c gene expression was decreased. Furthermore, there was no evidence for proteolytic regulation of SREBP-1 by the diets, as the ratio of mature to precursor protein was not significantly altered. These observations, together with the fact that the target genes for SREBP-1, fatty acid synthase, acetyl-CoA carboxylase, and ATP citrate lyase were not altered by fat ingestion, support the notion that SREBP-1c is not an important factor in regulating fatty acid synthesis following fatty acid influx in the intestine. In an earlier study, we also observed a marked dissociation (in fact, reciprocal association) between intestinal SREBP-1c expression and fatty acid synthesis in hamster intestine following changes in intestinal cholesterol flux (18). Thus, in the hamster intestine, under conditions of increased fatty acid (and cholesterol) flux, there is no correlation between changes in rates of fatty acid synthesis and SREBP-1c expression. Similarly, in CaCo-2 cells incubated with micelles containing fatty acids 18:0 or 18:1, rates of fatty acid synthesis were decreased without altering SREBP-1 mass or mRNA levels of SREBP-1c, fatty acid synthase, or acetyl-CoA carboxylase (23). Yet, in that same study, polyunsaturated fatty acids 18:2, 20:4, 20:5, or 22:6 suppressed fatty acid synthesis and caused a parallel decrease in expression of SREBP-1c. In addition, the liver X receptor agonist, T0901317, enhanced SREBP-1c gene and protein expression, and resulted in a significant increase in fatty acid synthesis (23). Thus, results obtained in cell culture may not reflect what happens in the intact animal. This seems particularly true for the SREBP pathway, as fairly marked differences have been observed in results from cell culture models versus intact animals (1, 10). In the hamster intestine, the results are clear. Under conditions of changes in cholesterol or fatty acid flux, the SREBP pathway, and in particular SREBP-1c, has little, if any, role in regulating fatty acid synthesis. In the liver, polyunsaturated fatty acids inhibit the expression of SREBP-1c compared with dietary saturated or monounsaturated fatty acids (13, 14). Moreover, n-3 polyunsaturated fatty acids appear to be more potent than n-6 polyunsaturated fatty acids in suppressing SREBP-1 expression. Our data in the intestine support the notion that polyunsaturated fatty acids, particularly n-3 polyunsaturated fatty acids, suppress SREBP-1c mRNA levels. SREBP-1c expression was significantly less in the proximal intestine of safflower oil and fish oil animals compared with palm oil and olive oil animals, with fish oil being more potent. Similarly, in CaCo-2 cells, micelles containing the polyunsaturated fatty acids 18:2, 20:4, 20:5, or 22:6 cause a decrease in mass and gene expression of SREBP-1 (23). Thus, although our data do not support a role of intestinal SREBP-1c in controlling fatty acid synthesis following lipid flux, our results do suggest that polyunsaturated fatty acids, particularly n-3 polyunsaturated fatty acids, suppress mRNA levels of SREBP-1c. In cell culture, it is thought that polyunsaturated fatty acids interfere with liver X receptor ligand activation of SREBP-1c (24). Whether this mechanism for regulating SREBP-1c expression occurs in vivo is unknown. The ingestion of fat did not alter total cholesterol mass, rates of cholesterol synthesis, or gene expression of SREBP-2 or HMG-CoA synthase. One might have expected an increased demand for cholesterol to ensure normal assembly and secretion of triacylglycerol-rich lipoproteins. Assuming that the amounts of biliary and dietary cholesterol remain similar, an obvious possible source is newly synthesized sterol. Because this did not occur, it suggests that biliary cholesterol and/or basal rates of intestinal cholesterol synthesis are sufficient to meet the cholesterol needs of the intestinal cells during times of enhanced lipoprotein production. Failure of increased fatty acid flux to enhance intestinal cholesterol synthesis was noted in earlier studies, also performed in hamsters (25, 26), and recently in CaCo-2 cells (23). Micellar fatty acids of different chain lengths and degrees of saturation did not alter SREBP-2 gene or protein expression, suggesting that the SREBP-2 pathway was not being activated following fatty acid influx. The results again are clear. In hamster intestine, increased dietary fatty acid flux does not change the expression of SREBP-2 nor does it alter cholesterol synthesis.
This work was supported by the Veterans Administration. The authors thank Drs. Jay Horton, M. S. Brown, and J. L. Goldstein, Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, for anti-SREBP-2 antibody. Manuscript received January 10, 2003 and in revised form March 4, 2003.
This article has been cited by other articles:
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||